These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12857416)

  • 1. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1.
    Dvorin EL; Wylie-Sears J; Kaushal S; Martin DP; Bischoff J
    Tissue Eng; 2003 Jun; 9(3):487-93. PubMed ID: 12857416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds.
    Sales VL; Engelmayr GC; Mettler BA; Johnson JA; Sacks MS; Mayer JE
    Circulation; 2006 Jul; 114(1 Suppl):I193-9. PubMed ID: 16820571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior Tissue Evolution in Slow-Degrading Scaffolds for Valvular Tissue Engineering.
    Brugmans MM; Soekhradj-Soechit RS; van Geemen D; Cox M; Bouten CV; Baaijens FP; Driessen-Mol A
    Tissue Eng Part A; 2016 Jan; 22(1-2):123-32. PubMed ID: 26466917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly-ε-caprolactone scaffold and reduced in vitro cell culture: beneficial effect on compaction and improved valvular tissue formation.
    Brugmans MM; Driessen-Mol A; Rubbens MP; Cox MA; Baaijens FP
    J Tissue Eng Regen Med; 2015 Dec; 9(12):E289-301. PubMed ID: 23677869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves.
    Sodian R; Hoerstrup SP; Sperling JS; Martin DP; Daebritz S; Mayer JE; Vacanti JP
    ASAIO J; 2000; 46(1):107-10. PubMed ID: 10667727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of basic fibroblast growth factor and transforming growth factor-beta on maturation of human pediatric aortic cell culture for tissue engineering of cardiovascular structures.
    Fu P; Sodian R; Lüders C; Lemke T; Kraemer L; Hübler M; Weng Y; Hoerstrup SP; Meyer R; Hetzer R
    ASAIO J; 2004; 50(1):9-14. PubMed ID: 14763486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds.
    Klouda L; Vaz CM; Mol A; Baaijens FP; Bouten CV
    J Mater Sci Mater Med; 2008 Mar; 19(3):1137-44. PubMed ID: 17701317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep.
    Mendelson K; Aikawa E; Mettler BA; Sales V; Martin D; Mayer JE; Schoen FJ
    Cardiovasc Pathol; 2007; 16(5):277-82. PubMed ID: 17868878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGA (polyglycolic acid)-P4HB (poly-4-hydroxybutyrate)-Based Bioengineered Valves in the Rat Aortic Circulation.
    Książek AA; Mitchell KJ; Cesarovic N; Schwarzwald CC; Hoerstrup SP; Weber B
    J Heart Valve Dis; 2016 May; 25(3):380-388. PubMed ID: 27989051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold.
    Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS
    J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of poly-glycolic acid-based hybrid polymer starter matrices for in vitro tissue engineering.
    Generali M; Kehl D; Capulli AK; Parker KK; Hoerstrup SP; Weber B
    Colloids Surf B Biointerfaces; 2017 Oct; 158():203-212. PubMed ID: 28697435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of compound biodegradable matrices and growth of vascular endothelial cell on them].
    Xiong M; Ai YF; Lu KH
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Sep; 16(5):303-6. PubMed ID: 12569799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves.
    Perry TE; Kaushal S; Sutherland FW; Guleserian KJ; Bischoff J; Sacks M; Mayer JE
    Ann Thorac Surg; 2003 Mar; 75(3):761-7; discussion 767. PubMed ID: 12645690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2.
    Paruchuri S; Yang JH; Aikawa E; Melero-Martin JM; Khan ZA; Loukogeorgakis S; Schoen FJ; Bischoff J
    Circ Res; 2006 Oct; 99(8):861-9. PubMed ID: 16973908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transforming growth factor-beta and growth differentiation factor-5 on proliferation and matrix production by human bone marrow stromal cells cultured on braided poly lactic-co-glycolic acid scaffolds for ligament tissue engineering.
    Jenner JM; van Eijk F; Saris DB; Willems WJ; Dhert WJ; Creemers LB
    Tissue Eng; 2007 Jul; 13(7):1573-82. PubMed ID: 17518729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro.
    Paranya G; Vineberg S; Dvorin E; Kaushal S; Roth SJ; Rabkin E; Schoen FJ; Bischoff J
    Am J Pathol; 2001 Oct; 159(4):1335-43. PubMed ID: 11583961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials.
    Engelmayr GC; Hildebrand DK; Sutherland FW; Mayer JE; Sacks MS
    Biomaterials; 2003 Jun; 24(14):2523-32. PubMed ID: 12695079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impregnation of plasmid DNA into three-dimensional scaffolds and medium perfusion enhance in vitro DNA expression of mesenchymal stem cells.
    Hosseinkhani H; Inatsugu Y; Hiraoka Y; Inoue S; Shimokawa H; Tabata Y
    Tissue Eng; 2005; 11(9-10):1459-75. PubMed ID: 16259601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.